about
Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission.Clinical signs and symptoms cannot reliably predict Plasmodium falciparum malaria infection in pregnant women living in an area of high seasonal transmission.Characterization of hepatitis delta virus in sub-Saharan Africa.Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy.Treatable causes of fever among children under five years in a seasonal malaria transmission area in Burkina Faso.Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trialImplementation of a malaria rapid diagnostic test in a rural setting of Nanoro, Burkina Faso: from expectation to realityCan clinical signs or symptoms combined with basic hematology data be used to predict the presence of bacterial infections in febrile children under - 5 years?The effect of malaria rapid diagnostic tests results on antimicrobial prescription practices of health care workers in Burkina FasoArtemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort studyAlgorithms for sequential interpretation of a malaria rapid diagnostic test detecting two different targets of Plasmodium species to improve diagnostic accuracy in a rural setting (Nanoro, Burkina Faso)Supporting evidence for a human reservoir of invasive non-Typhoidal Salmonella from household samples in Burkina Faso
P50
Q33617916-6BCECE76-A7D0-42FC-9AAE-5E39F03D867CQ33921620-DD8652CC-9DA7-42EC-B35A-ED75A736AC12Q37424929-2A32CEF1-CD9D-408F-9CA7-CA0358BE5EAAQ37713658-187022D3-18A5-44B7-91AD-8A5E8A53D173Q43929546-8C2A7E9D-86B3-4DB0-86F6-B1E7D6497990Q55475477-2E430863-F4AC-4E5F-AE47-EAFF3E84B51DQ56337574-C5CC0117-7408-44BC-A372-EE3703D44111Q58850608-B6F722A9-E2FA-49D5-9480-0FE06FB4ED6EQ59806586-5B42DB4C-E89F-4104-B060-CF8BD45223B0Q61443159-A9E584D6-3E2D-4279-8C1B-50B9A9BAF1A3Q64107927-94A59DE6-B7FE-4E40-A9DD-F7272EAAD8D7Q64240690-76E2EF66-B403-4DC5-94C2-6F3933E82549Q90694063-3139873E-8EB4-40AA-AF79-3352522CB4FD
P50
description
investigador
@es
researcher
@en
name
Christian M Tahita
@en
type
label
Christian M Tahita
@en
prefLabel
Christian M Tahita
@en
P31
P496
0000-0003-2158-0182